国产精品视频一区二区三区四,亚洲av美洲av综合av,99国内精品久久久久久久,欧美电影一区二区三区电影

官方微信|手機版

產(chǎn)品展廳

產(chǎn)品求購企業(yè)資訊會展

發(fā)布詢價單

化工儀器網(wǎng)>產(chǎn)品展廳>化工原料>生物化工醫(yī)藥>原料藥> S80050

S80050

具體成交價以合同協(xié)議為準

聯(lián)系方式:何小姐查看聯(lián)系方式

聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!


上海源葉生物科技有限公司是一家專門從事生物技術(shù)相關(guān)產(chǎn)品研發(fā)和銷售的綜合性生命科學公司,在全體員工的不懈努力和廣大客戶的大力支持下,公司迅速成長為一家擁有生物試劑部、實驗及醫(yī)用耗材部、生命科學儀器部以及技術(shù)服務部等部門的高新技術(shù)企業(yè)。





生物試劑,ELISA試劑盒,對照品,標準品,培養(yǎng)基,透析袋,病理科耗材,實驗室耗材

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Apabetalone (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively
  • 靶點: IC50: 510±41 nM (BD2), 87±10 μM (BD1)
  • 體內(nèi)研究: In the atherosclerosis prophylactic treatment study design, mice are fed a Western diet concurrent with the treatment with 150 mg/kg/dose b.i.d. for 12 weeks. Mice are sacrificed at 12 weeks after treatment. There is a progressive increase in body weight in both the vehicle treated as well as the Apabetalone (RVX-208) treated groups. However, there is only an increase of 4 g (from 24 g to 28 g) body weight after 12 weeks on Western diet in the Apabetalone treated group whereas this increase is found to be 9 g (25 g-34 g) in the vehicle treated group. The significant decrease in body weight gain in Apabetalone treated mice is not due to decreased feed consumption, suggesting a positive attribute of the molecule. Plasma lipid measurements are done at 6 weeks and 12 weeks of treatment with either the vehicle or Apabetalone. Compared to the vehicle control animals, Apabetalone treated mice show significant increase (~200%) in the levels of HDL-C at 6 weeks of treatment, which is sustained until end of the study (12 weeks)
  • 參考文獻:
    1. Picaud S, et al. RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19754-9. 2. McLure KG, et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS One. 2013 Dec 31;8(12):e83190. 3. Jahagirdar R, et al. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis. 2014 Sep;236(1):91-100.
  • 溶解度: DMSO  :  ≥  33  mg/mL  (89.09  mM)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.7 ml 13.499 ml 26.998 ml
    5 mM 0.54 ml 2.7 ml 5.4 ml
    10 mM 0.27 ml 1.35 ml 2.7 ml
    50 mM 0.054 ml 0.27 ml 0.54 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的性,僅供客戶參考交流研究之用。


化工儀器網(wǎng)

采購商登錄
記住賬號    找回密碼
沒有賬號?免費注冊

提示

×

*您想獲取產(chǎn)品的資料:

以上可多選,勾選其他,可自行輸入要求

個人信息:

溫馨提示

該企業(yè)已關(guān)閉在線交流功能

兴和县| 长治市| 甘泉县| 库伦旗| 乌拉特前旗| 阆中市| 临桂县| 庐江县| 大名县| 玉环县| 惠东县| 麻阳| 栖霞市| 正安县| 新平| 锡林郭勒盟| 久治县| 义乌市| 上犹县| 阳山县| 德钦县| 类乌齐县| 威宁| 房产| 诏安县| 江西省| 磐安县| 阳城县| 纳雍县| 东源县| 登封市| 呼和浩特市| 诸暨市| 景东| 沙雅县| 虎林市| 福州市| 日土县| 武汉市| 营山县| 房山区|